VAR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VAR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Varian Medical Systems's interest expense for the three months ended in Dec. 2020 was $ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2020 was $-11 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Varian Medical Systems's Operating Income for the three months ended in Dec. 2020 was $ 125 Mil. Varian Medical Systems's Interest Expense for the three months ended in Dec. 2020 was $ -1 Mil. Varian Medical Systems's Interest Coverage for the quarter that ended in Dec. 2020 was 96.08. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Varian Medical Systems's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varian Medical Systems Annual Data | |||||||||||||||||||||
Trend | Sep11 | Sep12 | Sep13 | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | |||||||||||
Interest Expense | Get a 7-Day Free Trial | -11.60 | -10.70 | -6.80 | -8.80 | -14.00 |
Varian Medical Systems Quarterly Data | ||||||||||||||||||||
Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | |
Interest Expense | Get a 7-Day Free Trial | -4.70 | -4.30 | -2.90 | -2.10 | -1.30 |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varian Medical Systems (NYSE:VAR) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Varian Medical Systems's Interest Expense for the three months ended in Dec. 2020 was $-1 Mil. Its Operating Income for the three months ended in Dec. 2020 was $125 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2020 was $102 Mil.
Varian Medical Systems's Interest Coverage for the quarter that ended in Dec. 2020 is calculated as
Interest Coverage | = | -1 | * | Operating Income (Q: Dec. 2020 ) | / | Interest Expense (Q: Dec. 2020 ) |
= | -1 | * | 124.9 | / | -1.3 | |
= | 96.08 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Jesse Michael Bruff | officer: SVP Finance, CFO | 3100 HANSEN WAY, PALO ALTO CA 94304 |
Magnus Momsen | officer: SVP, CAO, Corporate Controller | VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304 |
Dow R Wilson | director, officer: President and CEO | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Kolleen T Kennedy | officer: Pres. Proton Solutions, CGO | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Christopher A. Toth | officer: SVP and Pres. Oncology Systems | 1252 COOLIDGE AVE., SAN JOSE CA 95125 |
Michael Damon Hutchinson | officer: SVP,Chief Legal Officer, Secy | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Jean Luc Butel | director | ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
John W Kuo | officer: SVP, Gen Counsel and Secretary | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Judy Bruner | director | C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035 |
Beau Michelle Le | director | 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611 |
Anat Ashkenazi | director | LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285 |
Jeffrey R. Balser | director | 3657 RICHLAND AVE., NASHVILLE TN 37205 |
Regina E Dugan | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
David J Illingworth | director | 3100 HANSEN WAY PALO ALTO CA 94304 |
R Andrew Eckert | director | THREE RAVINIA DRIVE, ATLANTA GA 30346 |
From GuruFocus
By PRNewswire PRNewswire • 02-24-2021
By PRNewswire PRNewswire • 01-19-2021
By PRNewswire PRNewswire • 01-09-2021
By GuruFocus Research GuruFocus Editor • 05-17-2021
By GuruFocus Research GuruFocus Editor • 12-11-2020
By GuruFocus Research GuruFocus Editor • 05-18-2021
By PRNewswire PRNewswire • 04-27-2021
By GuruFocus Research GuruFocus Editor • 04-28-2021
By PRNewswire PRNewswire • 10-20-2020
By PRNewswire PRNewswire • 03-02-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.